Imunize El Paso El Paso, TX - 79936

Imunize El Paso is categorized under Vaccines and Other Immunizing Products in El Paso, TX and active since 2010.

Imunize El Paso was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Vaccines and Other Immunizing Products business, which does work in the B2B market, and is classified as a Vaccines and Other Immunizing Products, under code number 325414 by the NAICS.

If you are seeking more information, feel free to contact Diana Garcia at the company’s single location by writing to 1580 Grge Dter Drive # 102, El Paso, Texas TX 79936 or by phoning (915) 857-2474. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Imunize El Paso
Contact Person: Diana Garcia
Address: 1580 Grge Dter Drive # 102, El Paso, Texas 79936
Phone Number: (915) 857-2474
Website Address: immunizeelpaso.org
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Vaccines and Other Immunizing Products
SIC Code: 2836
NAICS Code: 325414
Share This Business:

Imunize El Paso was started in 2010 to provide professional Vaccines and Other Immunizing Products under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Diana Garcia for inquiries that concern Imunize El Paso by calling the company number (915) 857-2474, as your correspondence is most welcome. Additionally, the physical location of the single location of Imunize El Paso can be found at the coordinates 31.748935,-106.301577 as well as the street address 1580 Grge Dter Drive # 102 in El Paso, Texas 79936.

For its online presence, you may visit Imunize El Paso’s website at immunizeelpaso.org and engage with its social media outlets through on Twitter and on Facebook.